GlassScriptPhysician profile
Chandler Kramer
NPI 1326730615
$1,416.68
in general payments reported to CMS, 2019-2025
17 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $335 · 2024: $743 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,328 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,327.68 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $259.65 | 2023-2024 | Descovy |
| Viiv Healthcare Company | $213.99 | 2023-2024 | Apretude |
| Actelion Pharmaceuticals US, INC. | $203.01 | 2025 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $149.29 | 2023-2024 | Farxiga, Breztri |
| Merz North America, INC. | $107.51 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $96.40 | 2025 | |
| Intra-Sana Laboratories | $78.94 | 2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Astellas Pharma US INC | $57.57 | 2024 | Veozah |
| Pfizer INC. | $47.75 | 2024 | |
| Antares Pharma, INC. | $46.34 | 2024 | Xyosted |
| Amgen INC. | $35.80 | 2024 | Otezla |
| Halozyme INC | $31.49 | 2023 | |
| Abbvie INC. | $21.35 | 2024 | |
| Exact Sciences Corporation | $19.54 | 2025 | The Cologuard Plus Collection Kit |
| Cordis US Corp. | $19.38 | 2025 | Mynx Control Venous |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $15.28 | 2024 | Injectafer |
| Lilly USA, LLC | $13.39 | 2024 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandler Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.